Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
PGNY Stock | USD 23.54 0.29 1.25% |
Slightly above 51% of Progyny's investors are presently thinking to get in. The analysis of overall sentiment of trading Progyny stock suggests that some investors are interested at this time. Progyny's investing sentiment can be driven by a variety of factors including economic data, Progyny's earnings reports, geopolitical events, and overall market trends.
Progyny |
NEW YORK, Jan. 16, 2025 -- Progyny, Inc. , a transformative fertility, family building and womens health benefits solution, today ann
Read at gurufocus.com
Progyny Current Investor Sentiment
Panic Vs Confidence
51
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Progyny's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Progyny.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Progyny Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Progyny can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Progyny Historical Investor Sentiment
Investor biases related to Progyny's public news can be used to forecast risks associated with an investment in Progyny. The trend in average sentiment can be used to explain how an investor holding Progyny can time the market purely based on public headlines and social activities around Progyny. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Progyny's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Progyny and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Progyny news discussions. The higher the estimate score, the more favorable the investor's outlook on Progyny.
Progyny Maximum Pain Price Across April 17th 2025 Option Contracts
Progyny's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Progyny close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Progyny's options.
Progyny Fundamental Analysis
We analyze Progyny's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Progyny using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Progyny based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Progyny is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Progyny Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Progyny stock to make a market-neutral strategy. Peer analysis of Progyny could also be used in its relative valuation, which is a method of valuing Progyny by comparing valuation metrics with similar companies.
Peers
Progyny Related Equities
NRC | National Research | 2.39 | ||||
GDRX | Goodrx Holdings | 2.27 | ||||
VEEV | Veeva Systems | 2.05 | ||||
EVH | Evolent Health | 1.63 | ||||
TXG | 10X Genomics | 1.62 | ||||
SLP | Simulations Plus | 1.39 | ||||
HSTM | HealthStream | 1.36 | ||||
PHR | Phreesia | 1.01 | ||||
CERT | Certara | 0.79 | ||||
PRVA | Privia Health | 0.13 | ||||
TDOC | Teladoc | 0.1 | ||||
DH | Definitive Healthcare | 0.20 | ||||
HCAT | Health Catalyst | 1.95 |
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.